Clinical trial
Low Dose Unfractioned Heparin for Treatment of Sepsis Caused by Abdominal Infection:a Pilot Study
NCT04861922 is registered in ClinicalTrials.gov with The Third Xiangya Hospital of Central South University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Low Dose Unfractioned Heparin for Treatment of Sepsis Caused by Abdominal Infection:a Pilot Study
- Lead sponsor
- The Third Xiangya Hospital of Central South University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- May 11, 2021
- Completion date
- July 30, 2024
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gram-negative bacterial infections, heparin, sepsis